BC is a heterogeneous disease, and is currently divided into three major subtypes based on gene expression profiles: estrogen receptor (ER) positive (luminal A and B), human epidermal growth factor receptor (HER2) positive, and triple-negative BC (TNBC) [2,3]. The gene discussed is ESR1; the disease is breast cancer.